13
29th CInP WoRlD
ConGReSS 2014
Monday, 23 June 2014
| PRelIMInaRY SCIenTIfIC PRoGRaMMe
Inukshut at Sunset – Tourism Vancouver
Current perspectives on compulsivity
Trevor Robbins, United Kingdom
Clinical advances in obsessive-compulsive and related
disorders
Dan Stein, South africa
S-9
e
Symposium
15:00 – 17:00
Topic: neuroimaging (b)
Track: Translational
neuroimaging vulnerability to neuropsychiatric disorders
Chair:
Marco Leyton, Canada
Co-chair: Phil J. Cowen, United Kingdom
Using neuroimaging to identify neural markers of famil-
ial vulnerability to depression
Phil J. Cowen, United Kingdom
Neuroimaging the vulnerability to depression: The glu-
tamate system
Gregor Hasler, Switzerland
What underlies the onset of psychosis? Multi-modal and
longitudinal imaging data from people at risk of psychosis
oliver D. Howes, United Kingdom
PET studies of dopamine responses in subjects at risk for
substance use disorders
Marco leyton, Canada
PC-1
e
Pro-Con Debate
15:00 – 16:30
lithium is no longer needed as a mood stabiliser
W-3
e
Educational Workshop
15:00 – 16:00
Managing treatment resistance in psychiatry
W-4
e
Scientific Workshop
16:10 – 17:10
GPCRs and psychotherapeutic drug development
S-10
e
Symposium
15:00 – 17:00
Topic: neurodegenerative disorders:
Parkinson, alzheimer, Huntington, fronto-Temporal
Dementia, Vascular Dementia (a)
Track: Translational
Coming of age for phosphodiesterase inhibitors as central
nervous system therapeutics
Chair:
Jos Prickaerts, The Netherlands
Co-chair: Lawrence Wennogle, USA
Role of PDE-mediated signaling and its crosstalk in brain
function
akinori nishi, Japan
Role of cyclic nucleotides in cognitive function in the
brain
lawrence Wennogle, USa
PDE4 and PDE5 inhibitors in cognition enhancement:
From animals to humans and back again
Jos Prickaerts, The netherlands
Differential effects of PDE2, 4, 9 and 10 inhibition on
biochemical and behavioral markers of striatal function
Christopher Schmidt, USa
